The growing interest in NAD+ formulations, particularly at significant doses like 1000mg, is being amplified with the emerging profile of Retatrutide – a novel GLP-1 receptor activator gaining attention https://pageoftoday.com/story7800749/nad-product-retatrutide-a-uk-focus